Kanter J - Search Results

1

Incomplete implementation of guideline-based stroke prevention therapy in sickle cell disease.

Schlenz AM, Hayes J, Mueller M, Phillips S, Adams RJ, Kanter J. Schlenz AM, et al. Among authors: kanter j. Am J Hematol. 2018 Sep;93(9):E222-E224. doi: 10.1002/ajh.25163. Epub 2018 Aug 6. Am J Hematol. 2018. PMID: 29905391 Free PMC article. No abstract available.

2

A retrospective study to assess the utility of frequent laboratory monitoring of pediatric patients with sickle cell disease on hydroxyurea.

Nevin J, Myers L, Osunkwo I, Kanter J. Nevin J, et al. Among authors: kanter j. J Pediatr Hematol Oncol. 2014 Apr;36(3):e180-4. doi: 10.1097/MPH.0000000000000035. J Pediatr Hematol Oncol. 2014. PMID: 24072249

3

Management of sickle cell disease from childhood through adulthood.

Kanter J, Kruse-Jarres R. Kanter J, et al. Blood Rev. 2013 Nov;27(6):279-87. doi: 10.1016/j.blre.2013.09.001. Epub 2013 Sep 19. Blood Rev. 2013. PMID: 24094945 Free article. Review.

4

When is the optimal time to screen for Chlamydia in adolescents and young adults with sickle cell disease?

Bluett-Mills G, Kanter J. Bluett-Mills G, et al. Among authors: kanter j. Clin Pediatr (Phila). 2015 Feb;54(2):149-51. doi: 10.1177/0009922814545491. Epub 2014 Aug 6. Clin Pediatr (Phila). 2015. PMID: 25104729

5

Validation of a novel point of care testing device for sickle cell disease.

Kanter J, Telen MJ, Hoppe C, Roberts CL, Kim JS, Yang X. Kanter J, et al. BMC Med. 2015 Sep 16;13:225. doi: 10.1186/s12916-015-0473-6. BMC Med. 2015. PMID: 26377572 Free PMC article.

6

Needs Assessment for Patients with Sickle Cell Disease in South Carolina, 2012.

Schlenz AM, Boan AD, Lackland DT, Adams RJ, Kanter J. Schlenz AM, et al. Among authors: kanter j. Public Health Rep. 2016 Jan-Feb;131(1):108-16. doi: 10.1177/003335491613100117. Public Health Rep. 2016. PMID: 26843676 Free PMC article.

7

Assessing the Immunogenic Response of a Single Center's Pneumococcal Vaccination Protocol in Sickle Cell Disease.

Santoro JD, Myers L, Kanter J. Santoro JD, et al. Among authors: kanter j. J Pediatr Hematol Oncol. 2016 Apr;38(3):e102-6. doi: 10.1097/MPH.0000000000000510. J Pediatr Hematol Oncol. 2016. PMID: 26886376 Free PMC article.

8

Transcranial doppler re-screening of subjects who participated in STOP and STOP II.

Adams RJ, Lackland DT, Brown L, Brown D, Voeks J, Fullerton HJ, Kanter J, Kwiatkowski JL. Adams RJ, et al. Among authors: kanter j. Am J Hematol. 2016 Dec;91(12):1191-1194. doi: 10.1002/ajh.24551. Epub 2016 Oct 25. Am J Hematol. 2016. PMID: 27623561 Free PMC article. Clinical Trial.

9

Increased prevalence of potential right-to-left shunting in children with sickle cell anaemia and stroke.

Dowling MM, Quinn CT, Ramaciotti C, Kanter J, Osunkwo I, Inusa B, Iyer R, Kwiatkowski JL, Johnson C, Rhodes M, Owen W, Strouse JJ, Panepinto JA, Neumayr L, Sarnaik S, Plumb PA, Dlamini N, Kirkham F, Hynan LS; PFAST Investigators. Dowling MM, et al. Among authors: kanter j. Br J Haematol. 2017 Jan;176(2):300-308. doi: 10.1111/bjh.14391. Epub 2016 Oct 21. Br J Haematol. 2017. PMID: 27766637 Free PMC article.

10

Crizanlizumab for the Prevention of Pain Crises in Sickle Cell Disease.

Ataga KI, Kutlar A, Kanter J, Liles D, Cancado R, Friedrisch J, Guthrie TH, Knight-Madden J, Alvarez OA, Gordeuk VR, Gualandro S, Colella MP, Smith WR, Rollins SA, Stocker JW, Rother RP. Ataga KI, et al. Among authors: kanter j. N Engl J Med. 2017 Feb 2;376(5):429-439. doi: 10.1056/NEJMoa1611770. Epub 2016 Dec 3. N Engl J Med. 2017. PMID: 27959701 Free PMC article. Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

452 results

Search Page